FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
PMA: P160039
·
Supplement: S009
·
Decision Nov 9, 2023
Classifications
1
FEI Numbers
3
Registration Numbers
3
Basic Information
- Device Name
- Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
- Trade Name
- remede System IPG
- PMA Number
- P160039
- Supplement Number
- S009
- Device Class
- FDA Class 3
- Product Code
- PSR
- Generic Name
- Implanted phrenic nerve stimulator for central sleep apnea
- Medical Specialty
- Unknown
- Advisory Committee
- Anesthesiology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- November 9, 2023
- Date Received
- May 1, 2023
- Supplement Type
- Normal 180 Day Track
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
approval for introducing ease of use features to aid clinicians when during follow up visits and extending the shelf life the GEN 1.5 Model 1100/1600 IPGs packaging from 2 years to 4 years.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PSR | Implanted Phrenic Nerve Stimulator For Central Sleep Apnea | FDA class 3 | Unknown |